Title:
抗ＯＸ４０モノクローナル抗体とその応用
Document Type and Number:
Japanese Patent JP7346576
Kind Code:
B2
Abstract:
Provided in the present invention are an anti-OX40 monoclonal antibody or an antigen-binding fragment thereof, and a corresponding isolated polynucleotide, expression vector, recombinant cell, pharmaceutical composition, and application thereof. The present antibody can be used for the treatment of cancer or autoimmune disease.
Inventors:
In Hwang
Famin Chan
Han Gue
Famin Chan
Han Gue
Application Number:
JP2021537796A
Publication Date:
September 19, 2023
Filing Date:
December 25, 2018
Export Citation:
Assignee:
Hanks by Offer Matthews, Incorporated
International Classes:
C12N15/13; A61K39/395; A61K45/00; A61K48/00; A61P35/00; A61P37/06; A61P43/00; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N5/20; C12N15/63; C12N15/85; G01N33/15
Domestic Patent References:
| JP2018520657A | ||||
| JP2017514461A |
Foreign References:
| WO2018112346A1 |
Attorney, Agent or Firm:
Tadashige Ito
Tadahiko Ito
Osamu Miyazaki
Tadahiko Ito
Osamu Miyazaki